Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Arthritis & Rheumatism

• Publication date

  1998-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-XPMID 9811061
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome.

  1997cited by this paper
• Transcriptional activation of the alpha 1(I) procollagen gene in systemic sclerosis dermal fibroblasts. Role of intronic sequences.

  1996cited by this paper
• Characterization of a GC-rich Region Containing Sp1 Binding Site(s) as a Constitutive Responsive Element of the α2(I) Collagen Gene in Human Fibroblasts (*)

  1995cited by this paper
• Positive regulation of human α1 (I) collagen promoter activity by transcription factor Sp1

  1995cited by this paper
• Positive regulation of human alpha 1 (I) collagen promoter activity by transcription factor Sp1.

  1995cited by this paper
• Sp1 binding activity increases in activated Ito cells

  1995cited by this paper
• A Molecular Mechanism for Human T-cell Leukemia Virus Latency and Tax Transactivation (*)

  1995cited by this paper
• Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1.

  1994cited by this paper
• Mithramycin selectively inhibits collagen-alpha 1(I) gene expression in human fibroblast.

  1993cited by this paper
• Regulation of expression of the type I collagen genes.

  1993cited by this paper
• Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation.

  1992cited by this paper
• The transcriptional tissue specificity of the human pro alpha 1 (I) collagen gene is determined by a negative cis-regulatory element in the promoter.

  1992cited by this paper
• A pitfall of using a second plasmid to determine transfection efficiency.

  1992cited by this paper
• A procedure to standardize CAT reporter gene assay

  1992cited by this paper
• NF-I/Sp1 Switch Elements Regulate Collagen α1(I) Gene Expression

  1992cited by this paper
• NF-I/Sp1 switch elements regulate collagen alpha 1(I) gene expression.

  1992cited by this paper
• Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter

  1991cited by this paper
• Two different negative and one positive regulatory factors interact with a short promoter segment of the alpha 1 (I) collagen gene.

  1990cited by this paper
• Collagen gene expression.

  1989cited by this paper
• Analysis of the collagen alpha 1(I) promoter.

  1989cited by this paper
• Analysis of the collagen α(I) promoter

  1989cited by this paper
• Regulation of collagen gene expression.

  1989cited by this paper
• Selective activation of transcription by a novel CCAAT binding factor.

  1988cited by this paper
• Separate binding sites for nuclear factor 1 and a CCAAT DNA binding factor in the mouse alpha 2(I) collagen promoter.

  1987cited by this paper
• Regulatory elements in the first intron contribute to transcriptional control of the human alpha 1(I) collagen gene.

  1987cited by this paper
• Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts.

  1987cited by this paper
• Organization of the human pro-alpha 2(I) collagen gene.

  1987cited by this paper
• Elevated proα2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene

  1987cited by this paper
• A single polypeptide possesses the binding and transcription activities of the adenovirus major late transcription factor

  1986cited by this paper
• Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts.

  1986cited by this paper
• Differential binding of a CCAAT DNA binding factor to the promoters of the mouse alpha 2(I) and alpha 1(III) collagen genes.

  1986cited by this paper
• Fine structural analysis of the human pro-alpha 1 (I) collagen gene. Promoter structure, AluI repeats, and polymorphic transcripts.

  1985cited by this paper
• Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro.

  1985cited by this paper
• Increased type I collagen mRNA levels in cultured scleroderma fibroblasts.

  1984cited by this paper
• DNA sequence comparison of the regulatory signals at the 5' end of the mouse and chick alpha 2 type I collagen genes.

  1984cited by this paper
• Eukaryotic gene transcription with purified components.

  1983cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper
• Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

  1981cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture.

  1979cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper
• Lac repressor-operator interaction. I. Equilibrium studies.

  1970cited by this paper
• Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

  1969cited by this paper

• The hard problem: Mechanotransduction perpetuates the myofibroblast phenotype in scleroderma fibrosis

  2021cites this paper
• Trametinib prevents mesothelial-mesenchymal transition and ameliorates abdominal adhesion formation.

  2018cites this paper
• Cutaneous Fibrosis and Normal Wound Healing

  2017cites this paper
• MiR‐590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte‐Like Fate by Directly Repressing Specificity Protein 1

  2016cites this paper
• miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1

  2016cites this paper
• Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts

  2015cites this paper
• The polymorphism of type 1 collagen (COL1A1) gene does not correlate with an increased risk of foot ulcers in patients with diabetes mellitus.

  2014cites this paper
• Transcriptional control of collagen I gene expression.

  2014influential citation
• First description of the complete human xylosyltransferase-I promoter region

  2014cites this paper
• Strategies for anti-fibrotic therapies.

  2013cites this paper
• Sp1 mediates microRNA-29c-regulated type I collagen production in renal tubular epithelial cells.

  2013cites this paper
• Assessing the Activity of Agonistic Autoantibodies in Systemic Sclerosis and their Effects on Cultured Vascular Smooth Muscle Cells

  2012cites this paper
• Sp1king out cancer (....and fibrosis?)

  2012cites this paper
• Mithramycin reduces expression of fibro‐proliferative mRNAs in human gingival fibroblasts

  2011cites this paper
• The p65 Subunit of NF-κB Inhibits COL1A1 Gene Transcription in Human Dermal and Scleroderma Fibroblasts through Its Recruitment on Promoter by Protein Interaction with Transcriptional Activators (c-Krox, Sp1, and Sp3)*

  2011cites this paper
• Topical Mithramycin-A Modulates Submucosal Collagen Deposition after Esophageal Burn Injury in Rats

  2011cites this paper
• Melatonin augments expression of the procollagen α1 (I) and α1 (III) genes in the infarcted heart scar of pinealectomized rats

  2010cites this paper
• Function analysis of the promoter gene of the human COL1A1 and analysis of DNA binding factors in the transcription enhancement region.

  2010cites this paper
• Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis

  2010cites this paper
• Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults.

  2008cites this paper
• Mechanisms of osteoporosis associated with common allelic variants of the COL1A1 gene

  2008cites this paper
• Chondroitin sulphate decreases collagen synthesis in normal and scleroderma fibroblasts through a Smad-independent TGF-β pathway – implication of C-Krox and Sp1

  2008cites this paper
• Targeting of Sp1 transcription factor: a novel therapeutic approach for Keloids, an in vitro analysis

  2007cites this paper
• Human Collagen Krox Up-regulates Type I Collagen Expression in Normal and Scleroderma Fibroblasts through Interaction with Sp1 and Sp3 Transcription Factors*

  2007cites this paper
• A polymorphism in the CTGF promoter region associated with systemic sclerosis.

  2007cites this paper
• Systemic and localized scleroderma.

  2006cites this paper
• Proteasome blockade exerts an antifibrotic activity by coordinately down‐regulating type I collagen and tissue inhibitor of metalloproteinase‐1 and up‐regulating metalloproteinase‐1 production in human dermal fibroblasts

  2006cites this paper
• Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin.

  2006cites this paper
• Systemic sclerosis: hypothesis-driven treatment strategies.

  2006cites this paper
• Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis.

  2006cites this paper
• Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycin

  2005cites this paper
• B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts.

  2004cites this paper
• What did we learn by studying scleroderma fibroblasts?

  2004cites this paper
• Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis

  2004cites this paper
• Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.

  2003cites this paper
• Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts.

  2003cites this paper
• Systemic sclerosis: the susceptible host (genetics and environment).

  2003cites this paper
• Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

  2003cites this paper
• Transcriptional Inhibition of Type I Collagen Gene Expression in Scleroderma Fibroblasts by the Antineoplastic Drug Ecteinascidin 743*

  2003cites this paper
• Transcriptional activation of α1(III) procollagen gene in Tsk2/+ dermal fibroblasts

  2003cites this paper
• Regulation of procollagen I (α1) by interleukin‐4 in human bronchial fibroblasts: a possible role in airway remodelling in asthma

  2003cites this paper
• Transcriptional activation of alpha 1(III) procollagen gene in Tsk2/+ dermal fibroblasts.

  2003cites this paper
• Systemic sclerosis: current views of its pathogenesis.

  2003cites this paper
• [The pathogenesis of fibrosis in scleroderma].

  2003cites this paper
• Molecular aspects of scleroderma.

  2002cites this paper
• Modulation of transcriptional activity of collagen genes for the treatment of fibrotic diseases

  2002cites this paper
• Inhibition of Basal and Transforming Growth Factor-β-induced Stimulation of COL1A1 Transcription by the DNA Intercalators, Mitoxantrone and WP631, in Cultured Human Dermal Fibroblasts*

  2002cites this paper
• Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in Fibrosis

  2002cites this paper
• The genetics of systemic sclerosis

  2002cites this paper
• Tissue and molecular events in human conjunctival scarring in ocular cicatricial pemphigoid.

  2001cites this paper
• Blocking sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis.

  2001cites this paper
• Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.

  2001cites this paper
• Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin mice.

  2001cites this paper
• Regulation of matrix biosynthesis and degradation in systemic sclerosis

  2000cites this paper
• CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts.

  2000cites this paper
• Scleroderma and related disorders: therapeutic aspects.

  2000cites this paper
• Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene.

  2000cites this paper
• Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I.

  2000cites this paper
• Alterations in the regulation of expression of the αl(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma)

  2000cites this paper
• Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon

  2000cites this paper
• Novel therapeutic strategies in scleroderma

  1999cites this paper
• Transcriptional activation of the α1(I) procollagen gene and up-regulation of α1(I) and α1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice

  1998cites this paper
• Modulation of basal expression of the human alpha1(I) procollagen gene (COL1A1) by tandem NF-1/Sp1 promoter elements in normal human dermal fibroblasts.

  1998cites this paper